Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Altaras

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 1, 1993
Microhysteroscopy and endometrial biopsy results following failed diagnostic dilatation and curettage in women with postmenopausal bleedingM M Altaras, R Aviram, I Cohen, et al.
Gynecologic Oncology|March 1, 1997
Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patientsR Tepper, Y Beyth, M M Altaras, et al.
Human Reproduction (Oxford, England)|March 1, 1992
Hydatidiform mole coexisting with a fetus in twin gestation following gonadotrophin induction of ovulationM M Altaras, D J Rosen, I Ben-Nun, et al.
Gynecologic Oncology|October 1, 1986
The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovaryM M Altaras, G L Goldberg, W Levin, et al.
Gynecologic Oncology|June 1, 2000
Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancerA Fishman, A Klein, R Zemer, et al.
Gynecologic and Obstetric Investigation|March 28, 1998
Estrogen and progesterone receptors of adenomyosis in postmenopausal breast cancer patients treated with tamoxifenI Cohen, J Shapira, Y Beyth, et al.
Gynecologic Oncology|February 18, 1999
Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patientsI Cohen, A Figer, R Tepper, et al.
Journal of Clinical Pathology|September 4, 1999
Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecologically symptomatic and asymptomatic breast cancer patientsI Cohen, E Perel, D Flex, et al.
Gynecologic Oncology|January 1, 1997
Ovarian volume in postmenopausal breast cancer patients treated with tamoxifenI Cohen, M M Altaras, Y Beyth, et al.
Gynecologic Oncology|May 1, 1988
The role of cancer antigen 125 (CA 125) in the management of ovarian epithelial carcinomasM M Altaras, G L Goldberg, W Levin, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 1, 1993
Microhysteroscopy and endometrial biopsy results following failed diagnostic dilatation and curettage in women with postmenopausal bleedingM M Altaras, R Aviram, I Cohen, et al.
Gynecologic Oncology|March 1, 1997
Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patientsR Tepper, Y Beyth, M M Altaras, et al.
Human Reproduction (Oxford, England)|March 1, 1992
Hydatidiform mole coexisting with a fetus in twin gestation following gonadotrophin induction of ovulationM M Altaras, D J Rosen, I Ben-Nun, et al.
Gynecologic Oncology|October 1, 1986
The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovaryM M Altaras, G L Goldberg, W Levin, et al.
Gynecologic Oncology|June 1, 2000
Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancerA Fishman, A Klein, R Zemer, et al.
Gynecologic and Obstetric Investigation|March 28, 1998
Estrogen and progesterone receptors of adenomyosis in postmenopausal breast cancer patients treated with tamoxifenI Cohen, J Shapira, Y Beyth, et al.
Gynecologic Oncology|February 18, 1999
Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patientsI Cohen, A Figer, R Tepper, et al.
Journal of Clinical Pathology|September 4, 1999
Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecologically symptomatic and asymptomatic breast cancer patientsI Cohen, E Perel, D Flex, et al.
Gynecologic Oncology|January 1, 1997
Ovarian volume in postmenopausal breast cancer patients treated with tamoxifenI Cohen, M M Altaras, Y Beyth, et al.
Gynecologic Oncology|May 1, 1988
The role of cancer antigen 125 (CA 125) in the management of ovarian epithelial carcinomasM M Altaras, G L Goldberg, W Levin, et al.
Pageof 5